Myriad Genetics
MYGN
#7393
Rank
HK$4.15 B
Marketcap
HK$43.99
Share price
-1.58%
Change (1 day)
27.95%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -HK$3.03 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are HK$0.82 Billion. In 2025 the company made an earning of -HK$3.02 Billion a decrease over its 2024 earnings that were of -HK$0.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$3.03 Billion0.4%
2025 -HK$3.02 Billion218.91%
2024 -HK$0.95 Billion-53.49%
2023 -HK$2.04 Billion88.72%
2022 -HK$1.08 Billion172.08%
2021 -HK$0.4 Billion
2019 -HK$0.21 Billion-175.14%
2018 HK$0.27 B-70.81%
2017 HK$0.94 B22.22%
2016 HK$0.76 B-38.8%
2015 HK$1.25 B-6.12%
2014 HK$1.33 B-41.07%
2013 HK$2.27 B46.67%
2012 HK$1.54 B15.84%
2011 HK$1.33 B17.6%
2010 HK$1.13 B-15.96%
2009 HK$1.35 B
2007 -HK$0.33 Billion40.96%
2006 -HK$0.24 Billion
2003 -HK$0.27 Billion34.8%
2002 -HK$0.2 Billion89.21%
2001 -HK$0.11 Billion3.93%
2000 -HK$0.11 Billion21.76%
1999 -HK$83.42 Million-25.61%
1998 -HK$0.12 Billion38.83%
1997 -HK$80.77 Million-24.26%
1996 -HK$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
HK$63.80 B-2,208.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-HK$1.43 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.02 B-199.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-HK$0.28 Billion-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
HK$1.74 B-157.59%๐Ÿ‡บ๐Ÿ‡ธ USA